Koninklijke Philips (PHG) Net Income towards Common Stockholders (2009 - 2026)

Koninklijke Philips (PHG) recorded quarterly Net Income towards Common Stockholders of $187319.3 in Q1 2026, down 60.75% quarter-over-quarter from $477257.8 in Q4 2025, and up 122.6% on a YoY basis from $84150.8 in Q1 2025.

Koninklijke Philips (PHG) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends

Koninklijke Philips' Net Income towards Common Stockholders history runs 18 years deep, the most recent figure standing at $187319.3 for Q1 2026.

  • In Q1 2026, Net Income towards Common Stockholders rose 122.6% year-over-year to $187319.3; the TTM figure through Mar 2026 stood at $1.2 million (up 175.26% YoY), while the FY2025 annual figure was $1.0 billion, up 278654.97% from the prior year.
  • Net Income towards Common Stockholders was $187319.3 for Q1 2026 at Koninklijke Philips, down from $477257.8 in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $506137.2 in Q2 2024 to a low of -$1.5 million in Q3 2022.
  • Historically, Net Income towards Common Stockholders has averaged -$145286.9 across 5 years, with a median of $76224.7 in 2023.
  • The sharpest annual moves came in 2022 and 2024: Net Income towards Common Stockholders tumbled 495.44% in 2022, then jumped 564.01% in 2024.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at -$112227.2 in 2022, then tumbled by 369.77% to -$527210.6 in 2023, then gained by 29.06% to -$374008.4 in 2024, then jumped by 227.61% to $477257.8 in 2025, then plunged by 60.75% to $187319.3 in 2026.
  • The last three Net Income towards Common Stockholders figures came in at $187319.3 (Q1 2026), $477257.8 (Q4 2025), and $222120.5 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 157.80 Bn 151.14 Bn 6.27 Bn 1.08 Bn
2 Stryker 115.54 Bn 112.66 Bn 3.81 Bn 745.00 Mn
3 Medtronic 103.44 Bn 95.27 Bn 5.76 Bn 1.15 Bn
4 Boston Scientific 72.38 Bn 71.17 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 49.76 Bn 46.09 Bn 1.29 Bn -
6 Dexcom 29.53 Bn 28.42 Bn 750.30 Mn 199.50 Mn
7 GE HealthCare Technologies 29.51 Bn 27.44 Bn 1.98 Bn 411.00 Mn
8 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 187,319.30
9 Steris 20.69 Bn 20.27 Bn 697.10 Mn -
10 Zimmer Biomet Holdings 17.04 Bn 16.63 Bn 1.51 Bn 238.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 187,319.30
Dec 31, 2025 477,257.84
Sep 30, 2025 222,120.47
Jun 30, 2025 282,989.92
Mar 31, 2025 84,150.76
Dec 31, 2024 -374,008.39
Sep 30, 2024 208,661.71
Jun 30, 2024 506,137.16
Mar 31, 2024 -1.16 Mn
Dec 31, 2023 -527,210.56
Sep 30, 2023 97,973.14
Jun 30, 2023 76,224.71
Mar 31, 2023 -772,806.11
Dec 31, 2022 -112,227.21
Sep 30, 2022 -1.45 Mn
Jun 30, 2022 -21,341.13
Mar 31, 2022 -190,797.41
Dec 31, 2021 205,914.77
Sep 30, 2021 3.84 Mn
Jun 30, 2021 204,726.14